More than drugs: Voices of HIV-seropositive individuals with a history of substance use reveal a range of adherence factors

Journal of HIV/AIDS and Social Services

Volumn 6, Issue 1-2, 2007, Pages 161-179

  Gilbert, Dorie J ^a   Abel, Elizabeth A ^a   Francisco, Nancy Stewart ^b   Zilberman, Margarita ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b JACKSONVILLE STATE UNIVERSITY   (United States)

Author keywords

Adherence; AIDS; HIV; Stigma; Substance use

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DECISION MAKING; DISEASE PREVALENCE; DISEASE TREATMENT; DRUG; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34247137875     PISSN: 15381501     EISSN: 1538151X     Source Type: Journal    
DOI: 10.1300/J187v06n01_10     Document Type: Article

References (48)

1. Adam B., Maticka-Tyndale, E., & Cohen, J. (2003). Adherence practices among people living with HIV. AIDS Care, 15(2), 263.
2. Aloisi, M. S., Arici, C., Balzano, R., Noto, P., Piscopo, R., Filice, G. et al. (2002). Behavioral correlates of adherence to antiretroviral therapy. Journal of Acquired Immune Dificiency Syndromes, 31 S145-S148.
3. Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28, 47-58.
4. Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., & Howard, A. A. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. JGIM: Journal of General Internal Medicine, 17 5), 377-381.
5. Bangsberg, D. R., Hecht, F. M., & Charlebois, E. D. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357-366.
6. Bangsberg, D. R., Hecht, F. M., Clague, H., Charlebois, E. D., Ciccarone, D., & Chesney, M. et al. (2001). Provider assessment of adherence to HIV antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 26, 435-442.
7. Barfod, T., Sørensen, H., Nielsen, H., Rodkjær, L., & Obel, N. (2006). 'Simply forgot' is the most frequently stated reason for missed doses of HAART irrespective of degree of adherence. HIV Medicine, 7(5), 285-290.
8. Bassetti, S., Battegay, M., & Furrer, H. (1999). Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Journal of Acquired Immune Deficiency Syndrome, 21, 114-119.
9. Braitstein, P., Justice, A., Bangsberg, D. R., Yip, B., Alfonso, V., Schechter, M. T. et al. (2006). Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS, 20 (3), 323-331.
10. Celentano, D., Vlahov, D., Cohn, S., Shadle, V., Obasanjo, O., & Moore, R. (1998). Self-reported antiretroviral therapy in injection drug users. JAMA: Journal of the American Medical Association, 280(6), 544-547.
11. Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B. et al. (2000b). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12(3), 255-266.
12. Clarke, S., Delamere, S., McCullough, L., Hopkins, S., Bergin, C., & Mulcahy, F. (2003). Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Medicine, 4(1), 33-37.
13. Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of General Internal Medicine, 16, 83-88.
14. da Silveira, V., Drachler, M., Leite, J., & Pinheiro, C. (2003). Characteristics of HIV antiretroviral regimen and treatment adherence. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases, 7(3) 194-201.
15. Gebo, K., Keruly, J., & Moore, R. (2003). Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine, 18(2), 104-111.
16. Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentration in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23 386-395.
17. Golin, C. E., Liu, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J. et al. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756-765.
18. Gordillo, V., Del Amo, J., & Soriano, V. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
19. Halkitis, P. N., Kutnick, A. H., Borkowski, T., & Parsons, J. T. (2002). Adherence to HIV medications and club drug use among gay and bisexual men. XIV International AIDS Conference, abstract ThPeE7856. Barcelona, Spain.
20. Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N. et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS, 13, 1099-1107.
21. Ickovics, J. R., & Meade, C. S. (2002). Adherence to HAART among patients with HIV: Breakthroughs and barriers. AIDS Care, 14(3), 309-318.
22. Ingersoll, K. (2004). The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment AIDS Care, 16(2), 199-211.
23. Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E. et al. (2003). Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the Healthy Living Project, AIDS Patient Care & STDs 17(12), 645-656.
24. Johnson, M. O., Chesney, M. A., Goldstein, R. B., Remien, R. H., Catz, S., Gore-Felton, C. et al. (2006). Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model. AIDS Patient Care & STDs, 20 (4), 258-268.
25. Kerr, T., Marshall, A., Walsh, J., Palepu, A. Tyndall, M., Montaner, J. et al. (2005). Determinants of HAART discontinuation among injection drug users. AIDS Care, 17(5), 539-549.
26. Kremer, H., & Ironson, G. (2006). To tell or not to ten: Why people with HIV share or don't share with their physicians whether they are taking their medications as prescribed. AIDS Care, 18(5), 520-528.
27. Longshore, D., Grills, C., Anglin, M., & Annon, K. (1997). Desire for help among African American drug users. Journal of Drug Issues, 27(4), 755-770.
28. Lucas, G. M., Cheever, L. W., Chaisson, R. E., & Moore, R. D. (2001). Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. Journal of Acquired Immune Deficiency Syndrome, 27, 251-259.
29. Malcolm, S., Ng, J., Rosen, R., & Stone, V. (2003). An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care 15(2), 251.
30. Mannheimer, S., Curtis, J., & El-Sadr, W. (1999). Use of antiretroviral therapy by intravenous drug users with HIV. JAMA: The Journal of The American Medical Association, 281(8) 700.
31. Martini M., Recchia E., Nasta P., Castanotto D., Chiaffarino F., Parazzini F. et al. (2004). Illicit drug use: Can it predict adherence to antiretroviral therapy? European Journal of Epidemiology, 19 6 (Print)), 585-587.
32. Mellins, C. A., Kang, E., Leu, C., Havens, J., & Chesney, M. (2003). Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs, 17, 407-416.
33. Montessori, V., Press, N., Harris, M., Akagi, L., & Montaner, J. (2004). Adverse effects of antiretroviral therapy for HIV infection. CMAJ: Canadian Medical Association Journal = Journal De L'association Medicale Canadienne, 170(2 [Print]), 229-238.
34. Oggins, J. (2003). Notions of HIV and Medication among Multiethnic People Living with HIV. Health & Social Work 28(1), 53.
35. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. M., Squier, C. et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals Internal Medicine, 133, 21-30.
36. Power, R., Koopman, C., Volk, J., Israelski, D.M., Stone, L., Chesney, M. A. et al. (2003). Social support, substance use, and denial in relationship to antiretroviral treatment adherence among HIV-infected persons. AIDS Patient Care & STDs, 17(5), 245-252.
37. Prentiss, D. E., Balmas, M. G., Power, R., & Israelski, D. M. (2002). Use of marijuana among people with HIV and its relationship to adherence to antiretroviral treatment, use of alternative therapies and complete viral suppression in a public health care setting in northern California. XIV International AIDS Conference, abstract WePeB6008. Barcelona, Spain.
38. Read, T., Mijch, A., & Fairley, C. (2003). Adherence to antiretroviral therapy: Are we doing enough? Internal Medicine Journal, 33(5/6), 254-256.
39. Reback, C. J., Larkins, S., & Shoptaw, S. (2003). AIDS Care, 15 6), 775-785.
40. Sorensen, J., Mascovich, A., Wall, T., Dephilippis, D., Batki, S., & Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10(3), 297-312.
41. Stone, V. E., Hogan, J. W., & Schuman, P. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: Survey of women in the HER study. Journal of Acquired Immune Deficiency Syndrome, 28, 124-131.
42. Trochim, W. (1989). An introduction to concept mapping for planning and evaluation. Evaluation and Program Planning, 12(1), 1-16.
43. Tucker, J., Burnam, M., Sherbourne, C., Kung, F., & Gifford, A. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. American Journal of Medicine, 114(7), 573.
44. Turner, B., Fleishman, J. A., Wenger, N., London, A. S., Burnam, M. A., & Shapiro, M. F., (2001). Effects of drugs abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. Journal of General Internal Medicine, 16, 625-633.
45. Uldall, K., Palmer, N., Whetten, K., & Mellins, C. (2004). Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: A review of the literature. AIDS Care, 16, S71-S96.
46. Vlahov, D., & Celentano, D. (2006). Access to highly active antiretroviral therapy for injection drug users: Adherence, resistance, and death. Cadernos De Saúde Pública/Ministério Da Saúde, Fundaçno Oswaldo Cruz, Escola Nacional De Saúde Pública, 22(4 [Print]), 705-718.
47. Wagner, J. H., Justice, A. C., Chesney, M., Sinclair, G., Weissman, S., & Rodriguez-Barradas, M. (2001). Patient and provider-reported adherence: Toward a clinically useful approach to measuring antiretroviral adherence. Journal of Clinical Epidemiology, 54 S91-S98.
48. Ware, N., Wyatt, M., & Tugenberg, T. (2005). Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs. Social Science & Medicine, 61(3), 565-576.